Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir
Michael Neely, Andrea KovacsUniversity of Southern California Keck School of Medicine, Department of Pediatrics, Division of infectious Diseases, Los Angeles, CA, USAAbstract: Darunavir is currently the most recently approved HIV-1 protease inhibitor. It is approved for twice-daily dosing with riton...
Saved in:
| Main Authors: | , |
|---|---|
| 格式: | 圖書 |
| 出版: |
Dove Medical Press,
2009-07-01T00:00:00Z.
|
| 主題: | |
| 在線閱讀: | Connect to this object online. |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
因特網
Connect to this object online.3rd Floor Main Library
| 索引號: |
A1234.567 |
|---|---|
| 復印件 1 | 可用 |